Greillier L - Search Results

1

Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock?

Mogenet A, Greillier L, Tomasini P. Mogenet A, et al. Among authors: greillier l. Transl Lung Cancer Res. 2024 Oct 31;13(10):2856-2860. doi: 10.21037/tlcr-24-594. Epub 2024 Oct 17. Transl Lung Cancer Res. 2024. PMID: 39507024 Free PMC article. No abstract available.

2

[Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].

Marco S, Tomasini P, Greillier L, Barlesi F. Marco S, et al. Among authors: greillier l. Rev Mal Respir. 2011 Dec;28(10):1216-29. doi: 10.1016/j.rmr.2011.04.014. Epub 2011 Nov 4. Rev Mal Respir. 2011. PMID: 22152931 Review. French.

3

Ipilimumab: its potential in non-small cell lung cancer.

Tomasini P, Khobta N, Greillier L, Barlesi F. Tomasini P, et al. Among authors: greillier l. Ther Adv Med Oncol. 2012 Mar;4(2):43-50. doi: 10.1177/1758834011431718. Ther Adv Med Oncol. 2012. PMID: 22423263 Free PMC article.

4

The place of pemetrexed in the management of non-small-cell lung cancer patients.

Tomasini P, Greillier L, Khobta N, Barlesi F. Tomasini P, et al. Among authors: greillier l. Expert Rev Anticancer Ther. 2013 Mar;13(3):257-66. doi: 10.1586/era.12.171. Expert Rev Anticancer Ther. 2013. PMID: 23477511 Review.

5

[Regional molecular genetics centers in thoracic oncology: what and who should be tested?].

Barlesi F, Tomasini P, Fina F, Secq V, Greillier L, Nanni-Metellus I, Garcia S, Ouafik L. Barlesi F, et al. Among authors: greillier l. Bull Cancer. 2013 Jul-Aug;100(7-8):737-41. doi: 10.1684/bdc.2013.1774. Bull Cancer. 2013. PMID: 23823903 French.

6

Tumor relapse after thoracic surgery?

Garcia ME, Tomasini P, Thomas P, Greillier L, Barlesi F. Garcia ME, et al. Among authors: greillier l. J Thorac Oncol. 2015 Feb;10(2):397-8. doi: 10.1097/JTO.0000000000000333. J Thorac Oncol. 2015. PMID: 25611231 Free article. No abstract available.

7

[Ipilimumab and metastatic lung cancer: Can we change the natural history of the disease?].

Boyer A, Greillier L, Barazzutti H, Tomasini P, Barlesi F. Boyer A, et al. Among authors: greillier l. Rev Mal Respir. 2015 Nov;32(9):949-52. doi: 10.1016/j.rmr.2014.12.006. Epub 2015 Feb 26. Rev Mal Respir. 2015. PMID: 25725978 French.

8

Necitumumab for non-small cell lung cancer.

Greillier L, Tomasini P, Barlesi F. Greillier L, et al. Expert Opin Biol Ther. 2015;15(8):1231-9. doi: 10.1517/14712598.2015.1055243. Epub 2015 Jun 8. Expert Opin Biol Ther. 2015. PMID: 26051700 Review.

9

[Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].

Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi F. Fournier C, et al. Among authors: greillier l. Rev Mal Respir. 2016 Nov;33(9):751-756. doi: 10.1016/j.rmr.2015.12.009. Epub 2016 Mar 24. Rev Mal Respir. 2016. PMID: 27017063 French.

10

Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes.

Tomasini P, Barlesi F, Mascaux C, Greillier L. Tomasini P, et al. Among authors: greillier l. Ther Adv Med Oncol. 2016 May;8(3):198-208. doi: 10.1177/1758834016644155. Epub 2016 May 9. Ther Adv Med Oncol. 2016. PMID: 27239238 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters